Back to Search
Start Over
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)‐ERIBE.
- Source :
- Oncologist; Jun2019, Vol. 24 Issue 6, pe232-e240, 9p, 1 Diagram, 2 Charts, 3 Graphs
- Publication Year :
- 2019
-
Abstract
- <i>Copyright of Oncologist is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
- Subjects :
- BREAST cancer prognosis
ERIBULIN
ELDER care
GERIATRIC assessment
BREAST tumors
CANCER chemotherapy
CANCER relapse
MEDICAL cooperation
METASTASIS
SCIENTIFIC observation
QUALITY of life
QUESTIONNAIRES
RESEARCH
ACTIVITIES of daily living
TERMINATION of treatment
VISUAL analog scale
TREATMENT effectiveness
GERIATRIC Depression Scale
OLD age
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 10837159
- Volume :
- 24
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Oncologist
- Publication Type :
- Academic Journal
- Accession number :
- 137055201
- Full Text :
- https://doi.org/10.1634/theoncologist.2017-0676